Search

everythinglearnresearchcommunity

for

Search:↓

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Cicatricial alopecia may be caused by immune attacks on hair follicles, gland issues, or stem cell damage.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Blocking a specific immune cell signal can trigger hair growth.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Interleukin-15 can help hair growth and protect hair follicles.

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.